Recurrent Acute Pancreatitis in a Patient with Both Gallbladder And
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Vs. Endoscopic Retrograde Cholangiography in Biliary Sludge and Microlithiasis
10/7/2015 6:29:47 AM 150111 Therapeutic Effects of Ursodeoxycholic Acid (UDCA) Vs. Endoscopic Retrograde Cholangiography in Biliary sludge and Microlithiasis ﻣﺠﺎﺭﯼ ﺻﻔﺮﺍﻭﯼ Category : 8 Introduction : Biliary microlithiasis and sludge has been considered as a main cause of cute biliary pain and pancreatitis. The standard therapeutic approaches are medical and interventional .There is not enough data regarding usage and chose one of them .To determine the therapeutic values of ursodeoxycholic acid Vs. endoscopic retrograde cholangiography Methods : Between 2013 to 2015, patients who were referred to gastrointestinal clinic for follow-up of biliary sludge and microlithiasis enrolled to this study. The exclusion criteria were presence of CBD stone, CBD dilatation, history of papillotomy, any related complications and need of intervention. All of them underwent physical exam, abdominal ultrasonography and endoscopic. They randomly divided in two groups; medical and ERCP. Patients follow-up for six months .The clinical manifestations as well as lab data was compared in the end of study. Results : A total 116 patients was enrolled in this study .24 patients excluded for complications or needs intervention also 8 patients refused to continue. 7 and 5 patients of UDCA and ERCP groups respectively underwent cholecystectomy during our follow-up. Pancreatitis was seen in 5 patients; 4 and 1 in UDCA and ERCP group .the clinical manifestation as well as lab data were improve in both group but this improvement was significant in ERCP group. Conclusion : Usage of UDCA improves all symptoms as well as lab test .It could be ordered in weak patients or who is in waiting list of ERCP or Surgery. -
Rectal Indomethacin Or I.V. Gabexate Mesylate As Prophylaxis for AP ERCP
European Review for Medical and Pharmacological Sciences 2017; 21: 5268-5274 Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography V. GUGLIELMI, M. TUTINO, V. GUERRA, P. GIORGIO National Institute of Gastroenterology, “S. de Bellis” Research Hospital Castellana Grotte, Bari, Italy Abstract. – OBJECTIVE: We aimed to evaluate mechanisms of AP are obstruction of the com- the results in our case series of AP ERCP over mon bile duct by stones, and alcohol abuse. En- the last three years. The prophylaxis for acute doscopic retrograde cholangiopancreatography pancreatitis (AP) post-endoscopic retrograde (ERCP) is the most frequent iatrogenic cause. cholangiopancreatography (ERCP) consists of rectal indomethacin, but some studies are not Post-ERCP AP is the most common and fear concordant. some adverse event for this procedure. In the PATIENTS AND METHODS: We compared 241 United States this complication costs $150 mil- ERCP performed from January 2014 to February lion annually for American Healthcare2,3 and it 2015 with intravenous gabexate mesylate (Group is a common cause of endoscopy-related lawsu- A), with the 387 ERCP performed from March its against gastroenterologists in the world. It 2015 to December 2016 with rectal indometha- has a significant morbidity and rare mortality cin (Group B) as prophylaxis for AP post-ERCP. RESULTS: There were 8 (3.31%) AP post-ERCP rate. About 10% of post-ERCP AP is moderate in Group A vs. 4 (1.03%) in Group B. or severe. Post-ERCP severe AP is associated CONCLUSIONS: Rectal indomethacin shows a with a higher mortality than non-ERCP-indu- better statistically significant performance than ced pancreatitis, but without statistical eviden- intravenous gabexate mesylate in the prophylax- ce4. -
Sample Chapter CHAPTER 16: Liver, Biliary Tract, & Pancreas Disorders BUY
Sample Chapter CHAPTER 16: Liver, Biliary Tract, & Pancreas Disorders BUY NOW mhprofessional.com 728129654 – ©2021 McGraw Hill LLC. All Rights Reserved. CMDT 2022 677 Liver, Biliary Tract, & Pancreas Disorders Lawrence S. Friedman, MD 16 JAUNDICE & EVALUATION OF ABNORMAL hepatic uptake of bilirubin due to certain drugs; or impaired LIVER BIOCHEMICAL TESTS conjugation of bilirubin by glucuronide, as in Gilbert syn- drome, due to mild decreases in uridine diphosphate (UDP) glucuronyl transferase, or Crigler-Najjar syndrome, ESSENTIALS OF DIAGNOSIS caused by moderate decreases (type II) or absence (type I) of UDP glucuronyl transferase. Hemolysis alone rarely elevates the serum bilirubin level to more than 7 mg/dL » Jaundice results from accumulation of bilirubin in (119.7 mcmol/L). Predominantly conjugated hyperbiliru- body tissues; the cause may be hepatic or binemia may result from impaired excretion of bilirubin nonhepatic. from the liver due to hepatocellular disease, drugs, sepsis, » Hyperbilirubinemia may be due to abnormalities or hereditary hepatocanalicular transport defects (such as in the formation, transport, metabolism, or excre- Dubin-Johnson syndrome, progressive familial intrahe- tion of bilirubin. patic cholestasis syndromes, and intrahepatic cholestasis of » Persistent mild elevations of the aminotransferase pregnancy) or from extrahepatic biliary obstruction. Fea- levels are common in clinical practice and caused tures of some hyperbilirubinemic syndromes are summa- most often by nonalcoholic fatty liver disease rized in Table 16–2. The term “cholestasis” denotes (NAFLD). retention of bile in the liver, and the term “cholestatic jaundice” is often used when conjugated hyperbilirubine- » Evaluation of obstructive jaundice begins with ultrasonography and is usually followed by mia results from impaired bile formation or flow. -
Frey Operation for Chronic Pancreatitis Associated with Pancreas Divisum: Case Report and Review of the Literature
Case report Frey operation for chronic pancreatitis associated with pancreas divisum: case report and review of the literature Magdalena Skórzewska1, Tomasz Romanowicz2, Jerzy Mielko1, Andrzej Kurylcio1, Jan Pertkiewicz3, Robert Zymon2, Wojciech P. Polkowski1 1Department of Surgical Oncology, Medical University of Lublin, Poland 2Department of General and Oncological Surgery, Pope John Paul II Regional Hospital, Zamosc, Poland 3Olympus Endotherapy, Warsaw, Poland Prz Gastroenterol 2014; 9 (3): 175–178 DOI: 10.5114/pg.2014.43581 Key words: pancreas divisum, chronic pancreatitis, surgery. Address for correspondence: Prof. Wojciech P. Polkowski MD, PhD, Department of Surgical Oncology, Medical University of Lublin, 11 Staszica St, 20-081 Lublin, Poland, phone: +48 81 534 43 13, fax: +48 81 532 23 95, e-mail: [email protected] Abstract Pancreas divisum (PD) is the most common congenital anomaly of the pancreas, which increases susceptibility to recurrent pancreatitis. Usually, after failure of initial endoscopic therapies, surgical treatment combining pancreatic resection or drainage is used. The Frey procedure is used for chronic pancreatitis, but it has not been reported to be applied in an adult patient with PD-associated pancreatitis. The purpose of the paper was to describe effective treatment of this rare condition by the Frey procedure after failure of interventional endoscopic treatment. A 39-year-old female patient was initially treated for recurrent acute pancreatitis. After endoscopic diagnosis of PD, the minor duodenal papilla was incised and a plastic stent was inserted into the dorsal pancreatic duct. During the following 36 months, the patient was hospitalised several times because of recur- rent episodes of pancreatitis. Thereafter, local resection of the pancreatic head combined with lateral pancreaticojejunostomy was performed with no complications. -
A Gastric Duplication Cyst with an Accessory Pancreatic Lobe
Turk J Gastroenterol 2014; 25 (Suppl.-1): 199-202 An unusual cause of recurrent pancreatitis: A gastric duplication cyst with an accessory pancreatic lobe xxxxxxxxxxxxxxx Aysel Türkvatan1, Ayşe Erden2, Mehmet Akif Türkoğlu3, Erdal Birol Bostancı3, Selçuk Dişibeyaz4, Erkan Parlak4 1Department of Radiology, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey 2Department of Radiology, Ankara University Faculty of Medicine, Ankara, Turkey 3Department of Gastroenterological Surgery, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey 4Department of Gastroenterology, Türkiye Yüksek İhtisas Hospital, Ankara, Turkey ABSTRACT Congenital anomalies of pancreas and its ductal drainage are uncommon but in general surgically correctable causes of recurrent pancreatitis. A gastric duplication cyst communicated with an accessory pancreatic lobe is an extremely rare cause of recurrent pancreatitis, but an early and accurate diagnosis of this anomaly is important because suitable surgical treatment may lead to a satisfactory outcome. Herein, we presented multidetector com- puted tomography and magnetic resonance imaging findings of a gastric duplication cyst communicating with an accessory pancreatic lobe via an aberrant duct in a 29-year-old woman with recurrent acute pancreatitis and also reviewed other similar cases reported in the literature. Keywords: Aberrant pancreatic duct, accessory pancreatic lobe, acute pancreatitis, gastric duplication cyst, multi- detector computed tomography, magnetic resonance imaging INTRODUCTION Herein, we presented multidetector CT and MRI find- Report Case Congenital causes of recurrent pancreatitis include ings of a gastric duplication cyst communicating with anomalies of the biliary or pancreatic ducts, espe- an accessory pancreatic lobe via an aberrant duct in a cially pancreas divisum. A gastric duplication cyst 29-year-old woman with recurrent acute pancreatitis communicating with an aberrant pancreatic duct is and also reviewed other similar cases reported in the an extremely rare but curable cause of recurrent pan- literature. -
Intraductal Papillary Mucinous Carcinoma of The
Nishi et al. BMC Gastroenterology (2015) 15:78 DOI 10.1186/s12876-015-0313-3 CASE REPORT Open Access Intraductal papillary mucinous carcinoma of the pancreas associated with pancreas divisum: a case report and review of the literature Takeshi Nishi1,2*, Yasunari Kawabata2, Noriyoshi Ishikawa3, Asuka Araki3, Seiji Yano2, Riruke Maruyama3 and Yoshitsugu Tajima2 Abstract Background: Pancreas divisum, the most common congenital anomaly of the pancreas, is caused by failure of the fusion of the ventral and dorsal pancreatic duct systems during embryological development. Although various pancreatic tumors can occur in patients with pancreas divisum, intraductal papillary mucinous neoplasm is rare. Case presentation: A 77-year-old woman was referred to our hospital because she was incidentally found to have a cystic tumor in her pancreas at a regular health checkup. Contrast-enhanced abdominal computed tomography images demonstrated a cystic tumor in the head of the pancreas measuring 40 mm in diameter with slightly enhancing mural nodules within the cyst. Endoscopic retrograde pancreatography via the major duodenal papilla revealed a cystic tumor and a slightly dilated main pancreaticductwithanabruptinterruptionattheheadofthe pancreas. The orifice of the major duodenal papilla was remarkably dilated and filled with an abundant extrusion of mucin, and the diagnosis based on pancreatic juice cytology was “highly suspicious for adenocarcinoma”. Magnetic resonance cholangiopancreatography depicted a normal, non-dilated dorsal pancreatic duct throughout the pancreas. The patient underwent a pylorus-preserving pancreaticoduodenectomy under the diagnosis of intraductal papillary mucinous neoplasm with suspicion of malignancy arising in the ventral part of the pancreas divisum. A pancreatography via the major and minor duodenal papillae on the surgical specimen revealed that the ventral and dorsal pancreatic ducts were not connected, and the tumor originated in the ventral duct, i.e., the Wirsung’s duct. -
Albany Med Conditions and Treatments
Albany Med Conditions Revised 3/28/2018 and Treatments - Pediatric Pediatric Allergy and Immunology Conditions Treated Services Offered Visit Web Page Allergic rhinitis Allergen immunotherapy Anaphylaxis Bee sting testing Asthma Drug allergy testing Bee/venom sensitivity Drug desensitization Chronic sinusitis Environmental allergen skin testing Contact dermatitis Exhaled nitric oxide measurement Drug allergies Food skin testing Eczema Immunoglobulin therapy management Eosinophilic esophagitis Latex skin testing Food allergies Local anesthetic skin testing Non-HIV immune deficiency disorders Nasal endoscopy Urticaria/angioedema Newborn immune screening evaluation Oral food and drug challenges Other specialty drug testing Patch testing Penicillin skin testing Pulmonary function testing Pediatric Bariatric Surgery Conditions Treated Services Offered Visit Web Page Diabetes Gastric restrictive procedures Heart disease risk Laparoscopic surgery Hypertension Malabsorptive procedures Restrictions in physical activities, such as walking Open surgery Sleep apnea Pre-assesment Pediatric Cardiothoracic Surgery Conditions Treated Services Offered Visit Web Page Aortic valve stenosis Atrial septal defect repair Atrial septal defect (ASD Cardiac catheterization Cardiomyopathies Coarctation of the aorta repair Coarctation of the aorta Congenital heart surgery Congenital obstructed vessels and valves Fetal echocardiography Fetal dysrhythmias Hypoplastic left heart repair Patent ductus arteriosus Patent ductus arteriosus ligation Pulmonary artery stenosis -
Pancreas Divisum: Evaluation and Treatment of a Persistently Controversial Anatomic Finding
FRONTIERS IN ENDOSCOPY, SERIES #61 FRONTIERS IN ENDOSCOPY, SERIES #61 Douglas G. Adler MD, FACG, AGAF, FASGE, Series Editor Pancreas Divisum: Evaluation and Treatment of a Persistently Controversial Anatomic Finding Taylor Frost Douglas G. Adler INTRODUCTION ancreas divisum (literally, “divided pancreas”) condition.1 CFTR mutations may be present in is the most common anatomic variant of the up to 22% of patients with pancreas divisum who pancreas and is thought to exist in 5-10% of develop pancreatitis.2 P 36,37 the population. Pancreas divisum is the result of The majority of patients with pancreas divisum the failed fusion of the dorsal and ventral pancreatic will remain clinically asymptomatic and may buds early in development, resulting in the majority only be diagnosed incidentally in the context of of the pancreas being drained through the minor an imaging study ordered for another indication. papilla. (Figure 1) In patients with normal anatomy, However, some patients may be found to have the majority of the pancreas drains through the pancreas divisum in the setting of a history of, major papilla. More formally stated, in patients or investigation into, episodes of pancreatitis.3 It with pancreas divisum, the variant pancreatic has been proposed that a relatively stenotic minor ductal anatomy leads to the relatively large dorsal papilla may predispose patients with pancreas pancreas segment being drained through the minor divisum to recurrent episodes of pancreatitis.15 As papilla while the smaller ventral bud drains through such, in some cases patients are recommended to the major papilla. There is no known etiology undergo therapy for pancreas divisum, usually in the for pancreas divisum however, some genetic form of endoscopic minor papilla sphincterotomy abnormalities including mutations in the Cystic and/or endoscopic pancreatic duct stenting and, Fibrosis Transmembrane Conductance Regulator rarely, via surgical intervention. -
Carcinoid Tumor of the Minor Papilla in Complete Pancreas Divisum Presenting As Recurrent Abdominal Pain Yong Gil Kim, Tae Nyeun Kim*, Kyeong Ok Kim
Kim et al. BMC Gastroenterology 2010, 10:17 http://www.biomedcentral.com/1471-230X/10/17 CASE REPORT Open Access Carcinoid tumor of the minor papilla in complete pancreas divisum presenting as recurrent abdominal pain Yong Gil Kim, Tae Nyeun Kim*, Kyeong Ok Kim Abstract Background: Tumors of the minor papilla of the duodenum are extremely rare, and they are mostly neuroendocrine tumors, such as somatostatinomas and carcinoid tumors. However, true incidence of carcinoid tumors in minor papilla might be much higher, because patients with minor papillary tumors usually remain asymptomatic. We report a very unusual case of carcinoid tumor in a patient with complete pancreas divisum with a review of the literature. Case presentation: A 56-year-old female patient was referred for evaluation of pancreatic duct dilatation noted on abdominal ultrasonography and computerized tomography. She complained of intermittent epigastric pain for 6 months. A MRCP and ERCP revealed complete pancreas divisum with dilatation of the main pancreatic duct. On duodenoscopy, a small, yellows, subepithelial nodule was visualized at the minor papilla; biopsy of this lesion revealed a carcinoid tumor. She underwent a pylorus-preserving pancreaticoduodenectomy. The histologic evaluation showed a single nodule, 1 cm in diameter, in the submucosa with duodenal and vascular invasion and metastasis to the regional lymph nodes. Conclusion: Although the size of the carcinoid tumor was small and the tumor was hormonally inactive, the concomitant pancreas divisum led to an early diagnosis, the tumor had aggressive behavior. Carcinoid tumors of the minor papilla should be included in the differential diagnosis of recurrent abdominal pain or pancreatitis of unknown cause. -
Dr. Sreedevi* Dr. Santhaseelan Dr. Hema Vijayalakshmi V ABSTRACT KEYWORDS INTERNATIONAL JOURNAL of SCIENTIFIC RESEARCH
ORIGINAL RESEARCH PAPER Volume-8 | Issue-11 | November - 2019 | PRINT ISSN No. 2277 - 8179 | DOI : 10.36106/ijsr INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH EVALUATION OF UGI SCOPY FINDINGS FOR PRE- ELECTIVE LAPAROSCOPIC CHOLECYSTECTOMY TO PREVENT POST CHOLECYSTECTOMY SYNDROME General Surgery Dr. Ankush Misra Department Of General Surgery, Sree Balaji Medical College And Hospital, Chennai. Professer, Department Of General Surgery, Sree Balaji Medical College And Hospital, Dr. Sreedevi* Chennai. * Corresponding Author Professer, Department Of General Surgery, Sree Balaji Medical College And Hospital, Dr. Santhaseelan Chennai. Dr. Hema Department Of Medical Gastroenterology, Sree Balaji Medical College And Hospital, Vijayalakshmi V Chennai. ABSTRACT Background: Laparoscopic cholecystectomy is gold standard surgery for symptomatic gall stone disease which is the commonest disease needs surgical management. Symptomatology of the patients having upper GI pathologies can mimick the symptomatic gall stone disease and vice versa. Though biliary colic is specific for gallstones. Patients presenting with other gastrointestinal symptoms can also have gall stones. In this study UGI endoscopy was done for all patients with symptomatic and investigation proved gall stone disease to rule out other pathological causes of gastrointestinal tract and prevent post cholecystectomy syndrome. Methods: Patients with Ultrasonography suggestive of single or multiple gall stones were included. Upper GI Scopy was done prior to laparoscopic cholecystectomy as per inclusion and exclusion criteria. All patients above 18years, with ultrasonographically proven diagnosis of cholelithiasis Results: In present study, 153 patients were included. Pain in abdomen was present in 88.2% of patients. Nausea/vomiting was second most common symptom and seen in 60.78%. It is also seen that OGD findings were abnormal in 108 patients (i.e.70.58%) and OGD findings were normal in 45 patients. -
Diagnosis and Treatment of Pancreas Divisum: a Literature Review
Hepatobiliary & Pancreatic Diseases International 18 (2019) 332–336 Contents lists available at ScienceDirect Hepatobiliary & Pancreatic Diseases International journal homepage: www.elsevier.com/locate/hbpd Review Article Diagnosis and treatment of pancreas divisum: A literature review ∗ Valentina Ferri , Emilio Vicente, Yolanda Quijano, Benedetto Ielpo, Hipolito Duran, Eduardo Diaz, Isabel Fabra, Riccardo Caruso Division of General Surgery, Sanchinarro Hospital, San Pablo University, calle oña 10, 28050 Madrid, Spain a r t i c l e i n f o a b s t r a c t Article history: Background: Pancreas divisum is a congenital embryological disease caused by a lack of fusion between Received 3 October 2018 the ventral and dorsal pancreatic ducts in the early stages of embryogenesis. Recurrent acute pancreatitis, Accepted 13 May 2019 chronic pancreatitis or chronic abdominal pain are the main clinical syndromes at presentation and occur Available online 20 May 2019 in only 5% of the patients with pancreas divisum. This review aimed to discuss diagnosis and treatment Keywords: strategies in patients with symptomatic pancreas divisum. Pancreas divisum Data sources: We report a literature review from 1990 up to January 2018 to explore the various di- Duodenal-preserving pancreatectomy agnostic modalities and surgical techniques and results reported in the surgical treatment of pancreas Chronic pancreatitis divisum. Recurrent acute pancreatitis Results: There are limited reports available on this topic in the literature. We analyzed and described the main indications in the treatment of pancreas divisum, focusing on surgical treatment and a discussion of the different approaches. Furthermore, we report the results from our experience in two cases of pancreas divisum treated by pancreatic head resection with segmental duodenectomy (the Nakao procedure). -
Statistical Analysis Plan
Cover Page for Statistical Analysis Plan Sponsor name: Novo Nordisk A/S NCT number NCT03061214 Sponsor trial ID: NN9535-4114 Official title of study: SUSTAINTM CHINA - Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Document date: 22 August 2019 Semaglutide s.c (Ozempic®) Date: 22 August 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL Clinical Trial Report Status: Final Appendix 16.1.9 16.1.9 Documentation of statistical methods List of contents Statistical analysis plan...................................................................................................................... /LQN Statistical documentation................................................................................................................... /LQN Redacted VWDWLVWLFDODQDO\VLVSODQ Includes redaction of personal identifiable information only. Statistical Analysis Plan Date: 28 May 2019 Novo Nordisk Trial ID: NN9535-4114 Version: 1.0 CONFIDENTIAL UTN:U1111-1149-0432 Status: Final EudraCT No.:NA Page: 1 of 30 Statistical Analysis Plan Trial ID: NN9535-4114 Efficacy and safety of semaglutide once-weekly versus sitagliptin once-daily as add-on to metformin in subjects with type 2 diabetes Author Biostatistics Semaglutide s.c. This confidential document is the property of Novo Nordisk. No unpublished information contained herein may be disclosed without prior written approval from Novo Nordisk. Access to this document must be restricted to relevant parties.This